Drawing for ESTRACAP

USPTO serial 86391317

ESTRACAP

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GUTTADAURO, JULIE MARIE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ESTRACAP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew O. Brady

MATTHEW O. BRADY Allergan, Inc.2525 Dupont DriveIrvine, CA 92612UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Contraceptives; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial for inhibiting microbiological decomposition in pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidismACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 16, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 16, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 3, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Sep 20, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 19, 2017EX5GSOU EXTENSION 5 GRANTED—
Sep 7, 2017EXT5SOU EXTENSION 5 FILED—
Sep 7, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 17, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 16, 2017EX4GSOU EXTENSION 4 GRANTED—
Mar 8, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 1, 2017EXT4SOU EXTENSION 4 FILED—
Mar 1, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 30, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 9, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 8, 2016EX3GSOU EXTENSION 3 GRANTED—
Aug 30, 2016EXT3SOU EXTENSION 3 FILED—
Aug 30, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 9, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 8, 2016EX2GSOU EXTENSION 2 GRANTED—
Apr 6, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 9, 2016EXT2SOU EXTENSION 2 FILED—
Mar 9, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 23, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 22, 2015EX1GSOU EXTENSION 1 GRANTED—
Sep 21, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 9, 2015EXT1SOU EXTENSION 1 FILED—
Sep 9, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 10, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 13, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 13, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 24, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 10, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 10, 2014ALIEASSIGNED TO LIE—
Nov 26, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 25, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 24, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 24, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 1, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2014DOCKASSIGNED TO EXAMINER—
Sep 18, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 13, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance